/Companies

Alesta

Founded 2021 · 21 employees on LinkedIn · 8 known investors

Find your way into Alesta

Sign up to see every warm intro you have to Alesta

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alesta team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.

Founders & leadership

IGIlan Ganot
Ilan GanotCEO
BMBenit Maru
Benit MaruCMO
MVMatthias Van Woensel
Matthias Van WoenselCSOMatthias Van Woensel is Chief Scientific Officer at Alesta Therapeutics, a biotech company developing therapies for rare genetic diseases and oncology. He previously served as a partner at DROIA Ventures, an investment firm focused on oncology and genetic disease opportunities.

Investors · 8

Frequently asked questions

What does Alesta do?
Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.
Who are Alesta's investors?
Alesta's investors include Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, RV Invest GmbH, Frazier Healthcare Partners, MPM BioImpact, RTW Investments L.P., Thuja Capital.